(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of 15.74% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Precision Biosciences's revenue in 2025 is $51,141,000.On average, 1 Wall Street analysts forecast DTIL's revenue for 2025 to be $395,849,954, with the lowest DTIL revenue forecast at $395,849,954, and the highest DTIL revenue forecast at $395,849,954. On average, 1 Wall Street analysts forecast DTIL's revenue for 2026 to be $737,367,561, with the lowest DTIL revenue forecast at $737,367,561, and the highest DTIL revenue forecast at $737,367,561.
In 2027, DTIL is forecast to generate $839,379,314 in revenue, with the lowest revenue forecast at $839,379,314 and the highest revenue forecast at $839,379,314.